Official ESCRS | European Society of Cataract & Refractive Surgeons



Search Title by author or title

Sulcoflex trifocal supplementary IOL for presbyopia correction in pseudophakic eyes

Poster Details

First Author: D.Holland GERMANY

Co Author(s):    F. Rüfer   T. Herbst   I. Matthäi              

Abstract Details


.To evaluate the visual quality after bilateral implantation of a new additive trifocal sulcus IOL in pseudophakic patients.


nordBLICK Augenklinik Bellevue, Kiel, Germany


.The prospective study includes the first results after bilateral implantation of the new Sulcoflex trifocal in 10 pseudophakic eyes of 5 patients. All follow-up examinations were performed up to one month after surgery. Subjective refraction, uncorrected and corrected distance visual acuity, intermediate and near visual acuity were assessed.


The patients achieved postoperative a spherical equivalent of -0.30 ± 0.21 Dpt. The mean UCDVA is binocular 1,08 ± 0,13. The mean UCNVA is binocular 0,8±0,0 and UCINVA 0,92± 0,1. With correction binocular CDVA was 1,2± 0,13, DCIVA  0,96 ± 0,08 and DCNVA 0.84 ± 0.08. The defocus curve shows a good and stable rsults for uncorrected near and intermediate visual acuity. All patients achieved almost eyeglass independence in all visual ranges with very high patient satisfaction. No intra- or postoperative complications occurred.


The good functional results one month postoperatively show that Sulcoflex Trifocal is an good  option to treat pseudophakic patients with a trifocal optic to improve spectacle independence. Long-term investigations have to follow.  As the first additive trifocal IOL, Sulcoflex Trifocal is also a flexible, reversible alternative to trifocal intracapsular trifocal lenses.

Financial Disclosure:


Back to Poster listing